Drapkin Kimberlee C
Insider CIK 1340881 · PTI Director · ABOS Director · JNCE President, CFO and Treasurer · CLYM Director · GRPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-15 | 22,100 | — | $0 | 22,100 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2026-06-03 | 2026-06-05 | 53,250 | — | $0 | 53,250 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-06-03 | 2026-06-05 | 35,500 | — | $0 | 48,300 | SEC↗ |
| KANT KINETA, INC./DE | D To issuer deriv | 2025-06-30 | 2025-07-02 | 20,000 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | D To issuer | 2025-06-30 | 2025-07-02 | 13,794 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | A Award | 2025-06-25 | 2025-06-25 | 6,000 | — | $0 | 13,794 | SEC↗ |
| KANT KINETA, INC./DE | M Exercise deriv | 2025-06-23 | 2025-06-25 | 12,500 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | F Tax w/h | 2025-06-23 | 2025-06-25 | 4,706 | $0.26 | $1.2K | 7,794 | SEC↗ |
| KANT KINETA, INC./DE | M Exercise | 2025-06-23 | 2025-06-25 | 12,500 | $0.61 | $7.6K | 12,500 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-11 | 13,500 | — | $0 | 13,500 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2025-06-04 | 2025-06-05 | 19,500 | — | $0 | 19,500 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2025-06-04 | 2025-06-05 | 12,800 | — | $0 | 12,800 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-03-28 | 2025-04-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KA KINETA, INC./DE | A Award deriv | 2024-09-04 | 2024-09-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2024-06-10 | 2024-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 27,000 | — | $0 | 27,000 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2023-07-28 | 2023-08-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KA KINETA, INC./DE | A Award deriv | 2023-07-01 | 2023-07-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2023-06-06 | 2023-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 55,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 206,005 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 44,500 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 53,400 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 44,500 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 97,500 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 77,235 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 8,130 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | U Tender | 2023-05-03 | 2023-05-04 | 25,751 | — | $0 | 40,267 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | U Tender | 2023-05-03 | 2023-05-04 | 40,267 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-10 | 2023-01-11 | 7,781 | $1.12 | $8.7K | 66,018 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-11 | 6,315 | $1.10 | $6.9K | 73,799 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2022-04-01 | 2022-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 27,500 | — | $0 | 80,114 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-11 | 8,222 | $6.65 | $54.7K | 52,614 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-07 | 2022-01-11 | 4,595 | $7.30 | $33.5K | 60,836 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2021-06-02 | 2021-06-04 | 14,800 | — | $0 | 14,800 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 44,500 | — | $0 | 44,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2021-02-01 | 2021-02-03 | 22,250 | — | $0 | 65,431 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-21 | 2021-01-22 | 3,799 | — | $0 | 206,005 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-21 | 2021-01-22 | 3,799 | $2.36 | $9.0K | 46,980 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 3,799 | $12.00 | $45.6K | 43,181 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-20 | 2021-01-22 | 3,710 | — | $0 | 209,804 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-20 | 2021-01-22 | 6,775 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-20 | 2021-01-22 | 3,016 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-20 | 2021-01-22 | 3,710 | $2.36 | $8.8K | 69,382 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-20 | 2021-01-22 | 3,016 | $0.48 | $1.4K | 58,897 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-20 | 2021-01-22 | 6,775 | $0.74 | $5.0K | 65,672 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 10,000 | $10.03 | $100.3K | 43,181 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 16,201 | $12.03 | $194.9K | 53,181 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-08 | 2021-01-11 | 3,130 | $7.00 | $21.9K | 55,881 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-07 | 2021-01-11 | 2,697 | $6.76 | $18.2K | 59,011 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-09-01 | 2020-09-02 | 7,200 | $8.06 | $58.0K | 61,708 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-18 | 2020-08-18 | 744 | $4.71 | $3.5K | 68,908 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-17 | 2020-08-18 | 454 | $4.86 | $2.2K | 69,652 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-14 | 2020-08-18 | 984 | $4.64 | $4.6K | 70,106 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2020-06-29 | 2020-07-01 | 17,400 | — | $0 | 17,400 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-02-03 | 2020-02-04 | 53,400 | — | $0 | 53,400 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2020-02-03 | 2020-02-04 | 26,700 | — | $0 | 71,090 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-01-10 | 2,624 | $7.78 | $20.4K | 44,390 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-16 | 2019-08-16 | 1,018 | $3.92 | $4.0K | 47,014 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-15 | 2019-08-16 | 648 | $4.00 | $2.6K | 48,032 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-14 | 2019-08-16 | 670 | $4.10 | $2.7K | 48,680 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 44,500 | — | $0 | 44,500 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | A Award deriv | 2019-02-01 | 2019-02-05 | 30,600 | — | $0 | 30,600 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2019-02-01 | 2019-02-05 | 22,250 | — | $0 | 49,350 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-08-27 | 2018-08-28 | 12,700 | — | $0 | 213,514 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-08-27 | 2018-08-28 | 12,700 | $2.36 | $30.0K | 27,100 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2018-08-13 | 2018-08-15 | 14,400 | — | $0 | 14,400 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-03-08 | 2018-03-12 | 3,759 | — | $0 | 3,016 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-08 | 2018-03-12 | 5,267 | $25.01 | $131.7K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-03-08 | 2018-03-12 | 3,759 | $0.48 | $1.8K | 5,267 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 4,000 | $21.21 | $84.8K | 2,775 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 1,267 | $22.07 | $28.0K | 1,508 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 97,500 | — | $0 | 97,500 | SEC↗ |